NCT06712524 Effect of Different Surgical Approaches of Granulomatous Mastitis
| NCT ID | NCT06712524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hubei Cancer Hospital |
| Condition | Breast-conserving Plastic Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2024-11-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study was to prospectively investigate the effects of different surgical approaches on the recurrence rate and aesthetic outcome of patients with granulomatous mastitis. The patients were divided into traditional surgery group and plastic surgery group.
Eligibility Criteria
Inclusion Criteria: Only the subjects who meet all the following criteria may be included in this study: 1. Ability to understand the study procedures and contents, and willingness to voluntarily sign the written informed consent form; 2. 18≤Age≤75 years old, female; 3. Histologically confirmed granulomatous mastitis; 4. low and moderate risk for anesthesia. Exclusion Criteria: The subjects who meet any of the following criteria shall not be included in this study: 1. Absolute and relative contraindication for surgery; 2. Previous history of breast cancer or other malignancies; 3. Pregnancy; 4. Any serious complications which caused patients not suitable to participate this study.
Contact & Investigator
Xinhong Wu, Doctor
STUDY CHAIR
Hubei Cancer Hospital
Frequently Asked Questions
Who can join the NCT06712524 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast-conserving Plastic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06712524 currently recruiting?
Yes, NCT06712524 is actively recruiting participants. Contact the research team at zhenghongmeicj@163.com for enrollment information.
Where is the NCT06712524 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT06712524 clinical trial?
NCT06712524 is sponsored by Hubei Cancer Hospital. The principal investigator is Xinhong Wu, Doctor at Hubei Cancer Hospital. The trial plans to enroll 240 participants.